DxRuptive

DxRuptive develops rapid, low-cost, and simple-to-use technologies that will enable highly sensitive medical diagnostics and effective therapeutics for improved patient outcomes. The company maintains a pipeline of novel medical technologies at various stages of development. Our flagship product is a rapid diagnostic device capable of identifying (ID) causes of microbial infection and providing information on which antimicrobial treatments would be most effective (AST); all in less than one-quarter of the time of currently available tests.